U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07636395) titled 'Eating Behaviour Before, During, and After Obesity Medication' on May 21.
Brief Summary: This study will examine how eating behaviour changes during the first 18 months of treatment with obesity medications in patients attending the St Vincent's Healthcare Group obesity service. Obesity is increasingly understood as a chronic, relapsing, multifactorial disease that requires long-term management rather than short-term advice alone. Newer anti-obesity medications, particularly glucagon-like peptide-1 receptor agonists and related therapies, have improved weight-loss outcomes and altered the experience of hunger, fullness, food reward,...